Caption Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Sell |
19,000
-39,739
| -68% | -$1.31M | 0.01% | 296 |
|
|
2025
Q1 | $2.36M | Buy |
58,739
+3,909
| +7% | +$157K | 0.02% | 106 |
|
|
2024
Q4 | $2.58M | Buy |
54,830
+21,330
| +64% | +$1M | 0.02% | 97 |
|
|
2024
Q3 | $1.77M | Sell |
33,500
-33,500
| -50% | -$1.77M | 0.03% | 107 |
|
|
2024
Q2 | $3.63M | Sell |
67,000
-198,554
| -75% | -$10.8M | 0.06% | 49 |
|
|
2024
Q1 | $18.6M | Sell |
265,554
-154,805
| -37% | -$10.9M | 0.28% | 7 |
|
|
2023
Q4 | $35.1M | Buy |
420,359
+405,284
| +2,688% | +$33.8M | 0.47% | 4 |
|
|
2023
Q3 | $444K | Buy |
+15,075
| New | +$444K | 0.01% | 226 |
|
|
2023
Q1 | – | Sell |
-100,354
| Closed | -$4.6M | – | 469 |
|
|
2022
Q4 | $4.6M | Buy |
+100,354
| New | +$4.6M | 0.07% | 27 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 614 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 590 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 633 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 657 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 626 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 527 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 474 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 398 |
|
|
2020
Q3 | – | Sell |
-61,600
| Closed | -$1.45M | – | 410 |
|
|
2020
Q2 | $1.45M | Buy |
61,600
+19,864
| +48% | +$468K | 0.05% | 84 |
|
|
2020
Q1 | $492K | Buy |
+41,736
| New | +$492K | 0.03% | 143 |
|
|
2019
Q4 | – | Sell |
-14,400
| Closed | -$164K | – | 356 |
|
|
2019
Q3 | $164K | Sell |
14,400
-15,600
| -52% | -$178K | 0.01% | 204 |
|
|
2019
Q2 | $337K | Buy |
+30,000
| New | +$337K | 0.02% | 157 |
|